SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-029522
Filing Date
2023-08-21
Accepted
2023-08-21 09:00:10
Documents
12
Period of Report
2023-08-21
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 35101
  Complete submission text file 0001493152-23-029522.txt   209662

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vvos-20230821.xsd EX-101.SCH 3006
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vvos-20230821_lab.xml EX-101.LAB 34240
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vvos-20230821_pre.xml EX-101.PRE 22353
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3424
Mailing Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120
Business Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120 (866)908-4867
Vivos Therapeutics, Inc. (Filer) CIK: 0001716166 (see all company filings)

IRS No.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39796 | Film No.: 231187447
SIC: 3841 Surgical & Medical Instruments & Apparatus